4-Bromoquinazoline, 95.0%, 5g

6-Methylbenzo[d]isoxazole, 95+%, 250mg

2-[3-(Bromomethyl)-5-(1-cyano-1-methylethyl)phenyl]-2-methylpropanenitrile, 97.0%, 100mg

(4,6-Dimethoxypyridin-3-yl)boronic acid, 97.0%, 50mg

5-(3,4-Dichlorophenyl)-1,3,4-oxadiazol-2-amine, 97%, 100mg

2-Butanol, min 98,5 %, pour la synthèse, 10 l, PE/acier

Tetrakis(4-cyanophenyl)ethylene, 97%, 5g

1,3-Dimethyl-2-phenylbenzimidazoline, 97%, 250mg

4-Phenylbenzamide, 98+%, 5g

1-(1-Methyl-1H-benzimidazol-2-yl)ethanone, 95.0%, 1g

3-{[2-(2-methoxyethoxy)ethoxy]methyl}-3-methyloxetane, 97.0%, 5g

2,4,6-Tripyridyl-S-triazine, 99.0%, 5g

(1-METHYL-1H-INDAZOL-6-YL)METHANAMINE HCL, 95.0%, 250mg